16:26 EDT AbbVie sees Q2 EPS $2.75-$2.85, consensus $2.69
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ABBV:
- AbbVie (NYSE:ABBV) Trims 2023 EPS Outlook Ahead of Q2 Print
- AbbVie call volume above normal and directionally bullish
- Jacobio downgraded to Neutral from Buy at Goldman Sachs
- Nvidia upgraded, Apple initiated: Wall Street’s top analyst calls
- BeiGene downgraded to Market Perform from Outperform at Bernstein